Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03982043 · ClinicalTrials.gov registry record · NA

Text2Connect, Component 2 of iCHART (Integrated Care to Help At-Risk Teens)

A NA study of Depression and Suicidal Ideation, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
47
Enrollment target
4
Study locations

NCT03982043: Completed NA study of Depression and Suicidal Ideation, sponsored by University of Pittsburgh.

NCT03982043 is a NA study of Depression and Suicidal Ideation that has completed, run by University of Pittsburgh. The registered enrollment target is 47 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03982043, a NA study of Depression and Suicidal Ideation, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
4
Study locations

Study Summary

This study proposes to develop and examine a personalized, text-based intervention designed to improve engagement with mental health (MH) treatment.

Primary Outcome

Attendance to the embedded mental health care appointments will be assessed via electronic health record (EHR), as the primary outcome of Text2Connect (T2C)

Interventions

  • BEHAVIORAL Text2Connect

Study Locations (4)

Pennsylvania

  • CCP Waterdam - McMurray
  • Children's Community Pediatrics (CCP-Natrona Heights) of Children's Hospital of Pittsburgh of UPMC - Natrona Heights
  • Children's Community Pediatrics (CCP-GIL) of Children's Hospital of Pittsburgh of UPMC - Pittsburgh
  • STAR-Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2019-05-28
Est. Completion 2020-06-30
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT03982043 record still lists

NCT03982043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Text2Connect is the first listed.

NCT03982043 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03982043 about?

NCT03982043 is a clinical study titled "Text2Connect, Component 2 of iCHART (Integrated Care to Help At-Risk Teens)". This study proposes to develop and examine a personalized, text-based intervention designed to improve engagement with mental health (MH) treatment.

What is the current status of trial NCT03982043?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2019-05-28. Estimated completion is 2020-06-30.

What conditions does trial NCT03982043 study?

This clinical trial studies the following conditions: Depression, Suicidal Ideation.

What interventions are being tested in trial NCT03982043?

The interventions under investigation include: Text2Connect (BEHAVIORAL).

Who is sponsoring clinical trial NCT03982043?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03982043 being conducted?

This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03982043's enrollment target sits among peer trials

47 484th of 679 higher than 194 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT03982043, the US trial registry maintained by the National Library of Medicine. NCT03982043 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.